21 CFR 211.142 Warehousing Procedures: A Practical Guide

What does 21 CFR 211.142 actually say?

Section 211.142, titled "Warehousing procedures," is one of the shortest regulations in Part 211, and I think that is exactly why it causes trouble. The full requirement is two sentences long. It says written procedures describing the warehousing of drug products shall be established and followed, and that they shall include:

(a) Quarantine of drug products before release by the quality control unit.
(b) Storage of drug products under appropriate conditions of temperature, humidity, and light so that the identity, strength, quality, and purity of the drug products are not affected.

That is the whole text. There is no number in it. It does not say 2°C to 8°C, it does not say how often to map a warehouse, and it does not tell you what an alarm limit should be. FDA left the specifics to you, which means an investigator will judge your procedures against what your own product, your own stability data, and your own labeling say they should be.

A short rule with no numbers is a rule you have to defend with your own evidence. That is the practical meaning of 211.142 for most sites.

The regulation sits in Subpart H of 21 CFR Part 211, "Holding and Distribution," next to 211.150 on distribution procedures. It applies to finished drug products. Components, containers, closures, and labeling have their own storage rules elsewhere in the same part, and I cover those below because auditors routinely walk across that boundary.

Who has to comply with 211.142?

Any manufacturer, packager, relabeler, or contract facility that holds finished drug products and is subject to Part 211. That includes the warehouse sitting inside your plant, the third-party logistics provider holding released goods on your behalf, and a contract manufacturer storing your product between packaging and shipment.

The last two cases trip people up. Under 21 CFR 211.22(a), the quality control unit is responsible for approving or rejecting products manufactured, processed, packed, or held under contract by another company. Outsourcing the pallet does not outsource the obligation. If a 3PL holds your quarantined or released product, your quality agreement and your oversight have to show that 211.142 is being met at their dock.

How do you write a warehousing SOP that satisfies 211.142?

Section 211.100(a) requires written procedures for production and process control, and 211.142 requires warehousing procedures specifically. In practice I expect one controlling SOP, with supporting procedures underneath it, covering at least the following.

1. Receipt and status identification

The SOP should define how finished product arrives in the warehouse, who verifies it against the transfer documentation, and how its status is shown at every moment. Status is the heart of the quarantine requirement. Every pallet, tote, or shipper needs a status that is visible and unambiguous: quarantine, released, rejected, or on hold.

2. Quarantine before release (211.142(a))

Product stays in quarantine until the quality control unit releases it. Release authority sits with QC under 211.22, and the warehouse procedure should say so plainly. Define:

Where quarantined product physically lives, or how it is controlled electronically if you use a validated warehouse management system.
What documentation QC must complete before status changes, typically batch record review under 211.192 and completed testing under 211.165.
Who may move product out of quarantine, and how that is recorded.
What happens to product on hold or rejected, including segregation and disposition.

3. Storage conditions (211.142(b))

The SOP needs to name the storage conditions for each product or product family and point back to the source of those conditions, normally the approved labeling and the stability data supporting it. Section 211.166 requires a written stability testing program, and 211.137 ties expiration dating to storage conditions. If your label says "Store at 20° to 25°C," your warehouse has to be able to prove it kept the product there.

4. Stock rotation and issue

Section 211.150(a) requires a procedure whereby the oldest approved stock of a drug product is distributed first, with deviations permitted only if temporary and appropriate. Many sites run first-expired, first-out, which is a sensible way to meet the spirit of that clause, but write down which rule you follow and why.

5. Traceability for recall

Section 211.150(b) requires a system by which the distribution of each lot can be readily determined to facilitate recall if necessary. Your warehousing records should let you answer "where is lot X right now, and where did it go?" without a scavenger hunt.

6. Returns and holds

Section 211.204 says returned drug products shall be identified as such and held. If the conditions under which they were held, stored, or shipped cast doubt on safety, identity, strength, quality, or purity, they must be destroyed unless examination, testing, or other investigation proves otherwise. A warehouse that mixes returns into saleable stock has a serious problem.

What temperature, humidity, and light conditions count as "appropriate"?

Appropriate means whatever your product needs, demonstrated by data. Most labels, though, use USP storage vocabulary, and the General Notices of the USP define those terms. Here is how the common categories compare.

Storage category	Typical label language	Defined range (USP General Notices)	Warehouse implication
Controlled room temperature	"Store at 20° to 25°C"	20°–25°C, with excursions permitted between 15° and 30°C, and mean kinetic temperature not more than 25°C	Monitor continuously; excursions up to 30°C need a documented assessment against MKT
Refrigerated	"Store in a refrigerator, 2° to 8°C"	2°–8°C	Qualified cold room or refrigerated unit, calibrated sensors, alarm response procedure
Frozen	"Store in a freezer"	−25° to −10°C	Qualified freezer, backup power plan, defined thaw and re-freeze rules
Cool	"Store in a cool place"	Not more than 8°C (refrigerator) or between 8° and 15°C	Check what the label means in context before assigning a zone
Protect from light	"Store in original carton"	Container or packaging that prevents light transmission	Keep product in secondary packaging; control open-case storage under bright lighting
Protect from moisture	"Store in tightly closed container"	Per label and container-closure data	Humidity monitoring where stability data show sensitivity

If your labeled storage conditions differ from the table, your labeling wins. I would not treat USP definitions as a substitute for reading the actual label and the stability report.

For humidity, the reference point many manufacturers use is ICH Q1A(R2), which lists 25°C ± 2°C / 60% RH ± 5% RH as the long-term condition for climatic zones I and II and 30°C / 75% RH for zone IVb. Those are stability testing conditions, not warehouse limits, but they tell you what humidity range your data actually support. If your product was never studied above 60% RH and your warehouse sits in a humid region without dehumidification, you have a gap that 211.142(b) will expose. For more on how stability programs feed storage claims, see our stability testing guide.

How do you prove a warehouse holds its conditions?

Section 211.142(b) says conditions must be appropriate, and an investigator will ask how you know. There is no clause that says "perform a temperature mapping study," but the evidence expectation is clear from the combination of 211.142, 211.68, 211.160(b)(4), and 211.58. In my experience, a defensible program has these pieces.

Temperature mapping

Map the warehouse, cold room, or freezer under loaded and, where practical, empty conditions, in summer and winter extremes. Place sensors at the corners, near doors, near HVAC supply and return, at the top and bottom of racking, and at the center. The point is to find hot and cold spots, then decide where product may be stored and where permanent monitors go. Re-map after significant changes such as new racking layouts, HVAC modifications, or capacity changes.

Continuous monitoring

A min/max thermometer read once a day will not tell you what happened overnight. Continuous monitoring with defined alarm limits and an alarm response procedure is the norm for cold chain and increasingly for controlled room temperature areas. If you use an electronic system, remember that 211.68 covers automatic, mechanical, and electronic equipment, and that Part 11 applies to electronic records and signatures. Validate the system for its intended use. Our article on validating AI systems in FDA-regulated GMP environments covers the same validation thinking if your monitoring platform has analytics layered on top, though that link is optional reading for a basic setup.

Calibration

Section 211.160(b)(4) requires calibration of instruments, apparatus, gauges, and recording devices at suitable intervals under a written program with specific directions, schedules, limits for accuracy and precision, and provisions for remedial action. Your warehouse temperature and humidity sensors are covered. Use reference standards traceable to NIST or an equivalent national standard, and document what happens when a sensor is found out of tolerance, including a look back at product that was stored under it.

Alarm limits and response

Set alert and action limits tighter than the label limits so you have time to react. Write down who gets the alarm at 2 a.m., what they do in the first fifteen minutes, and when quality is notified. An alarm nobody can answer is a finding waiting to be written.

What should you do when there is a temperature excursion?

Every warehouse has them. What separates a mature program from a weak one is the documented decision that follows. Under 211.192, any unexplained discrepancy must be thoroughly investigated, and the investigation records must include conclusions and follow-up. Treat an excursion the same way.

A workable excursion procedure covers these steps:

Quarantine the affected product immediately and apply a hold status.
Record the actual temperature profile: start, peak, duration, and recovery.
Compare the profile to what the stability data support. Manufacturers often hold supportive excursion data from stability studies or specific temperature-excursion studies.
Have the quality unit make and document a disposition decision. Release, reject, or test further, each with a rationale.
Find the root cause and take corrective action, whether that is an HVAC fault, a door left open, or a failed compressor.
Trend excursions so recurring problems show up before an inspector points them out.

The decision to use product that saw an excursion belongs to quality, and it must rest on data. A hunch that "it was only a few hours" will not hold up.

How does 211.142 relate to other warehouse requirements?

Auditors do not stay inside one section number. The warehouse is evaluated against a web of related rules. This table maps the main ones.

Regulation	Subject	Warehouse relevance
21 CFR 211.42(c)(7)–(8)	Design and construction, defined areas	Separate areas or controls for quarantine storage and storage after release
21 CFR 211.46	Ventilation, air filtration, heating and cooling	Environmental control where storage conditions require it
21 CFR 211.56	Sanitation	Written cleaning procedures and pest control (211.56(c)) apply to storage areas
21 CFR 211.80	Components, containers, closures	Raw material storage: off the floor, spaced for cleaning and inspection (211.80(c)), lot-identified (211.80(d))
21 CFR 211.122 and 211.125	Labeling and packaging materials	Labeling stored in a way that prevents mix-ups, with access limited to authorized personnel
21 CFR 211.150	Distribution procedures	Oldest approved stock first, recall traceability
21 CFR 211.204	Returned drug products	Identify and hold returns, evaluate before any reprocessing or destruction

The distinction I would underline is between 211.142 and 211.80. Section 211.80 handles incoming components and containers, and 211.142 handles finished product. Many sites write a single "warehouse SOP" that blurs both and ends up not satisfying either cleanly. I prefer separate sections, or separate documents, so a reviewer can find the finished-goods quarantine logic without wading through raw material receiving.

What about gmp cold storage and cold chain warehouses?

Cold storage does not have its own Part 211 section. It is 211.142(b) applied to a product whose label says 2°C to 8°C or colder. The expectations I have just described all apply, with added weight:

Qualified equipment. Cold rooms, refrigerators, and freezers should be qualified (installation, operation, and performance), with mapping data.
Backup power. A written plan for generator or alternative storage when power fails.
Packaging validation. If cold-chain product leaves the building, shipping configurations should be validated for the lanes and seasons you use.
Door and loading discipline. Many cold-chain excursions happen at the dock, not in the room. Define maximum time out of temperature for staging.
Segregation. Quarantined and released cold product need physical or system-controlled separation just as ambient product does.

If you hold product for distribution to wholesalers or pharmacies, also consider other regimes outside Part 211, such as the Drug Supply Chain Security Act and 21 CFR Part 205 for wholesale distributors. Those are separate from 211.142, but a single warehouse often falls under several.

What do FDA investigators typically cite in warehouses?

I would rather speak from patterns than quote statistics I cannot source. The recurring problems I see in warehouse observations and in mock audits fall into a handful of buckets:

Quarantine controls that rely on a handwritten tag or an informal habit rather than a defined, followed procedure.
Storage conditions in the SOP that do not match the approved labeling.
Sensors that were never mapped to worst-case locations, or that were out of calibration.
Excursions closed without a documented, data-based disposition.
Returns stored alongside saleable goods.
Pest control records missing or not tied to the written procedure required by 211.56(c).
Third-party warehouses with no current quality agreement and no recent audit.

Notice that most of these are failures to follow, not failures to write. Section 211.142 says procedures shall be "established and followed," and the second half of that phrase is where most citations land.

Warehouse compliance checklist for 21 CFR 211.142

Use this as a self-inspection list. If you cannot answer yes with a document in hand, you have work to do.

Procedures and responsibilities

[ ] A written warehousing SOP exists, is approved by the quality unit, and is current.
[ ] The SOP covers quarantine, storage conditions, stock rotation, returns, and holds.
[ ] Release authority is assigned to the quality control unit in writing.
[ ] Warehouse personnel are trained on the SOP and training is documented (21 CFR 211.25).

Quarantine and status

[ ] Every container or pallet carries a visible, unambiguous status.
[ ] Quarantined, released, rejected, and on-hold product are physically or electronically segregated.
[ ] Status changes require documented QC action.
[ ] Any warehouse management system that controls status is validated.

Storage conditions

[ ] Storage conditions for each product match the approved label and stability data.
[ ] Temperature (and humidity where relevant) have been mapped under representative conditions.
[ ] Continuous monitoring is in place with alarm limits and a documented response plan.
[ ] Sensors are calibrated under a written program with traceable standards.
[ ] Light-sensitive products are kept in protective packaging.

Excursions and deviations

[ ] A written excursion procedure exists and requires a quality disposition.
[ ] Excursion investigations are documented, trended, and linked to CAPA where needed.

Distribution and traceability

[ ] A defined stock rotation rule is followed (211.150(a)).
[ ] Lot distribution can be traced quickly for recall (211.150(b)).
[ ] Returns are identified, held, and evaluated per 211.204.

Facility and third parties

[ ] Cleaning and pest control follow written procedures (211.56).
[ ] Records are retained for at least one year after the expiration date of the lot (211.180(a)).
[ ] Contract warehouses have a quality agreement and recent audit evidence.

For a broader view of warehouse and distribution expectations, our article on GMP warehouse storage and distribution requirements goes further into layout, controls, and day-to-day practice.

Where should you start if your warehouse program is thin?

Begin with the label. Pull the storage statement for every product you hold, then check that your SOP, your zone assignments, and your monitoring limits all say the same thing. In my view, that single reconciliation catches more real problems than any other exercise, because mismatches between what the label promises and what the warehouse delivers are the easiest thing for an investigator to spot.

After that, look at status control and excursion handling, since those are where the quality unit's authority shows up in the physical world. If a pallet can move from quarantine to saleable without anyone from QC touching it, no amount of beautiful mapping data will save you.

What would your warehouse look like to someone walking in cold with only the SOP in their hand?

Last updated: 2026-11-10

Frequently Asked Questions

What does 21 CFR 211.142 require?

It requires written warehousing procedures for drug products that are established and followed, and that include (a) quarantine of drug products before release by the quality control unit and (b) storage under appropriate conditions of temperature, humidity, and light so identity, strength, quality, and purity are not affected.

Does 21 CFR 211.142 specify temperature ranges?

No. The regulation gives no numeric limits. Appropriate conditions are set by the product's approved labeling and supporting stability data, commonly expressed using USP storage terms such as controlled room temperature (20° to 25°C) or refrigerated (2° to 8°C).

Is temperature mapping required for pharmaceutical warehouses?

Part 211 does not use the words 'temperature mapping,' but mapping is the usual way to demonstrate that storage conditions required by 211.142(b) are maintained, alongside calibrated monitoring under 211.160(b)(4). Investigators commonly expect it for cold rooms and controlled room temperature areas.

Who can release drug product from quarantine under 211.142?

The quality control unit. Under 21 CFR 211.22, QC has the responsibility and authority to approve or reject drug products, including those held under contract by another company, so warehouse staff should not change status without documented QC action.

Does 211.142 apply to third-party warehouses?

Yes, in practice. The drug manufacturer remains responsible under 211.22(a) for products held under contract, so a quality agreement, qualification, and periodic audits of the third-party warehouse are needed to show 211.142 is being followed.